Literature DB >> 6813170

No rationale for antiplatelet drug treatment in diabetic ketoacidosis.

H U Janka, H Mehnert.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 6813170     DOI： 10.1007/bf00252858

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  4 in total

1.  The release of a human platelet specific protein measured by a radioimmunoassay.

Authors:  C A Ludlam; S Moore; A E Bolton; D S Pepper; J D Cash
Journal:  Thromb Res       Date:  1975-06       Impact factor: 3.944

2.  Course and prognosis of 86 episodes of diabetic coma. A five year experience with a uniform schedule of treatment.

Authors:  U Keller; W Berger; R Ritz; P Truog
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

3.  Haemostatic changes in diabetic coma.

Authors:  R C Paton
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

4.  Differential renal effects of cyclooxygenase inhibition in sodium-replete and sodium-deprived dog.

Authors:  M C Blasingham; A Nasjletti
Journal:  Am J Physiol       Date:  1980-10
  4 in total
  1 in total

1.  Antiplatelet/anticoagulant drug therapy in severely uncontrolled diabetes mellitus.

Authors:  P Carroll; R Matz
Journal:  Diabetologia       Date:  1983-04       Impact factor: 10.122
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.